This article gives an overview of the current state of the evidence for prostate cancer early detection with prostate-specific antigen (PSA) and summarizes current recommendations from guideline groups. The article reviews the global public health burden and risk factors for prostate cancer with clinical implications as screening tools. Screening studies, novel biomarkers, and MRI are discussed. The article outlines 7 key practice points for primary care physicians and provides a simple schema for facilitating shared decision-making conversations.
Keywords: Biomarkers; Magnetic resonance imaging; Prostate cancer; Prostate-specific antigen; Screening.
Copyright © 2020 Elsevier Inc. All rights reserved.